CompletedNot applicableNCT03141125

The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Indonesia University
Principal Investigator
Harry Isbagio, MD, Prof.
Department of Internal Medicine
Intervention
Physalis angulata ethanol extract(other)
Enrollment
62 enrolled
Eligibility
18-60 years · All sexes
Timeline
20162017

Study locations (2)

Collaborators

Netherlands: Ministry of Health, Welfare and Sports

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03141125 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis

← Back to all trials